Oscar Health (OSCR) news

Oscar Health, Inc.: UBS raises target price to $36 from $26

UBS has raised its price target for Oscar Health, Inc. (NASDAQ: OSCAR) to $36 from $26, reflecting a positive reassessment of the company’s outlook. The adjustment indicates the firm’s increased confidence in Oscar Health’s strategic direction and operational performance. Analysts at UBS did not…

Cuprina Holdings (Cayman) - To buy East Coast Podiatry and Orchard Clinic for S$4.0 mln (US$3.1 mln)

Cuprina Holdings (Cayman) has announced the acquisition of East Coast Podiatry and Orchard Clinic for S$4.0 million (US$3.1 million). The transaction, which reflects the company's strategic expansion into the healthcare sector, is expected to strengthen its presence in podiatric services and…

Oscar Health announces Thrive Capital’s completion of Oscar Health common stock distribution to its limited partners

Oscar Health (NYSE: OSCR) has announced the completion of a distribution of its common stock to limited partners of Thrive Capital, a major investment firm and significant shareholder in the health-tech company. The distribution follows a series of strategic transactions and reflects the ongoing…

Oscar Health, Inc.: Raymond James raises target price to $42 from $34

Raymond James analyst Matthew Borsch has raised his price target for Oscar Health, Inc. (NASDAQ: OSCAR) to $42 from $34, reflecting improved expectations for the company’s financial performance and strategic direction. The analyst cited Oscar Health’s progress in expanding its Medicare Advantage…

Oscar Health, Inc.: Piper Sandler raises target price to $48 from $36